CRNX
Crinetics Pharmaceuticals Inc
NASDAQ: CRNX · HEALTHCARE · BIOTECHNOLOGY
$38.78
+0.88% today
Updated 2026-04-30
Market cap
$3.99B
P/E ratio
—
P/S ratio
519.04x
EPS (TTM)
$-4.95
Dividend yield
—
52W range
$26 – $58
Volume
1.1M
Crinetics Pharmaceuticals Inc (CRNX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $589000.00 | $2.04M | $2.43M | $1.19M | $71000.00 | $1.08M | $4.74M | $4.01M | $1.04M | $7.70M |
| Revenue growth (YoY) | — | +247.2% | +18.7% | -50.9% | -94.0% | +1418.3% | +339.4% | -15.3% | -74.1% | +640.7% |
| Cost of revenue | $5.10M | $9.23M | $24.48M | $41.51M | $57.00M | $1.26M | $1.39M | $1.10M | $2.79M | $4.97M |
| Gross profit | $-4.51M | $-7.19M | $2.43M | $1.19M | $71000.00 | $1.08M | $4.74M | $4.01M | $1.04M | $2.73M |
| Gross margin | -765.9% | -351.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 35.5% |
| R&D | $5.10M | $9.23M | $24.48M | $41.51M | $57.00M | $84.25M | $130.22M | $168.53M | $240.16M | $332.06M |
| SG&A | $1.53M | $1.94M | $6.66M | $13.52M | $18.03M | $24.52M | $42.39M | $58.09M | $99.74M | $191.33M |
| Operating income | $-6.04M | $-9.13M | $-28.71M | $-53.83M | $-74.95M | $-107.70M | $-167.88M | $-222.61M | $-338.85M | $-516.77M |
| Operating margin | -1026.1% | -446.3% | -1182.5% | -4512.3% | -105567.6% | -9990.9% | -3544.1% | -5547.2% | -32613.5% | -6714.8% |
| EBITDA | $-5.95M | $-9.00M | $-28.24M | $-52.95M | $-74.00M | $-106.78M | $-166.90M | $-221.51M | $-336.07M | $-461.25M |
| EBITDA margin | -1010.5% | -440.0% | -1163.1% | -4438.0% | -104232.4% | -9905.4% | -3523.3% | -5519.8% | -32345.4% | -5993.3% |
| EBIT | $-6.04M | $-9.13M | $-28.71M | $-53.83M | $-74.95M | $-107.70M | $-167.88M | $-222.61M | $-338.85M | $-465.14M |
| Interest expense | $11000.00 | $8000.00 | $0.00 | $0.00 | $991000.00 | $61000.00 | $4.32M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.02M | $-9.16M | $-27.11M | $-49.53M | $-72.86M | $-106.72M | $-159.95M | $-214.53M | $-298.41M | $-465.32M |
| Net income growth (YoY) | — | -52.1% | -196.1% | -82.7% | -47.1% | -46.5% | -49.9% | -34.1% | -39.1% | -55.9% |
| Profit margin | -1021.9% | -447.8% | -1116.8% | -4152.1% | -102625.4% | -9899.7% | -3376.7% | -5345.9% | -28720.7% | -6046.2% |